TRANSGENE
Biotechnology · Healthcare
1 appearance
Latest appearance 2026-03-24
Analyst
Van Lanschot Kempen
Equibles does not estimate personal net worth.
Chiara Montiori is recorded as Analyst at Van Lanschot Kempen. Chiara Montiori has spoken on 1 earnings call across 1 company, most recently for TRANSGENE on March 24, 2026. The companies whose calls Chiara Montiori spoke on are classified in the Healthcare sector.
“I actually have a couple, so the first one, how should we be looking at the three years DFS data that are approaching in Q2, Q3, given that the primary endpoint and the benchmark are at two years?”
Van Lanschot Kempen
Analyst
Transcript header (unverified)
TRANSGENE
Biotechnology · Healthcare
2025 Full-year Results
TRANSGENE